Amyris (AMRS) Stock: Strong Ahead of Earnings

Amyris Inc (NASDAQ: AMRS)

Amyris is having an incredibly strong day in the market today, and for good reason. The company is expected to report its earnings soon, and investors have reason to be excited. Today, we’ll talk about the coming earnings report, what we’re seeing from the stock, and what we can expect to see from AMRS ahead.

AMRS To Report Earnings Soon

As mentioned above, Amyris is having a relatively strong day in the market today as investors await earnings. The truth is that there is a very good reason for the gains we’re seeing in the value of the stock. At the end of the day, according to press releases and company announcements, the company has had a great quarter!

At the moment, analysts are expecting that AMRS will report a loss of $0.05 per share, bringing it closer than it has ever been to profits. However, it is entirely possible that the company completely blows this away and surprises investors with a profitable quarter. After all, there was a new product release during the quarter, and that likely lead to revenue.

What We’re Seeing From The Stock

As investors, we know that investor excitement definitely has the potential to move the market. With earnings just around the corner, and a strong quarter by way of fundamental news behind us, investors are definitely excited. As a result, we’re seeing gains. Currently (12:00), AMRS is trading at $1.07 per share after a gain of $0.04 per share or 3.95% thus far today.

What We Can Expect To See Ahead

Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from Amyris. First and foremost, let’s chat about the short term. In the short, I’m expecting to see further gains in the value of the stock leading up to and following earnings. There are several changes that we’ve seen throughout the quarter, and we haven’t seen too many earnings revisions. As a result, I’m expecting that AMRS will beat expectations, exciting investors and leading to strong gains in the value of the stock.

However, the earnings report isn’t the only reason I’m excited about the stock. Over the past year, we’ve seen incredible activity from the company with regard to new collaborations. Throughout this time, the company has collaborated with the United States government, biotechnology companies, neutraceuticals companies, fragrance and flavors companies, and more. With a proven ability to develop proprietary chemicals, the company is laying the ground work for incredible gains ahead.

Think about it this way. If only 50% of the collaboration agreements led to a profitable product, AMRS would stand to gain a massive amount of money in the long run. With an incredible track record, there’s no reason to expect that this won’t be the case.

With that said, the long run gets brighter and brighter with each new collaboration agreement. Considering the activity we’ve seen from the company throughout the year, I’m expecting that profitability and big gains are just around the corner for AMRS.

What Do You Think?

Where do you think AMRS is headed moving forward? Join the discussion in the comments below!